BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35274748)

  • 1. Peritumoral matrilin-2 staining may be useful in distinguishing basal cell carcinoma from folliculocentric basaloid proliferation.
    Wang Z; Lee J; Breen C; Ruenger T; Xiong F; Goreshi R; Lu M; Iwamoto S
    J Cutan Pathol; 2022 Jun; 49(6):543-548. PubMed ID: 35274748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basaloid neoplasms in nevus sebaceus.
    Kaddu S; Schaeppi H; Kerl H; Soyer HP
    J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
    Chaudet KM; Stagner AM; Nazarian RM
    Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
    Flordelis JO; Shen YC; Wu YH
    J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy.
    Longo C; Lallas A; Kyrgidis A; Rabinovitz H; Moscarella E; Ciardo S; Zalaudek I; Oliviero M; Losi A; Gonzalez S; Guitera P; Piana S; Argenziano G; Pellacani G
    J Am Acad Dermatol; 2014 Oct; 71(4):716-724.e1. PubMed ID: 24928707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes.
    Lesack K; Naugler C
    BMC Dermatol; 2012 Mar; 12():1. PubMed ID: 22405101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
    Bartoš V
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T-cells.
    Ressler JM; Zila N; Korosec A; Yu J; Silmbrod R; Bachmayr V; Tittes J; Strobl J; Lichtenberger BM; Hoeller C; Petzelbauer P
    J Cutan Pathol; 2023 Jun; 50(6):544-551. PubMed ID: 36562598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
    Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
    J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited.
    Leshin B; White WL
    Arch Dermatol; 1990 Jul; 126(7):900-6. PubMed ID: 2360837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma-Associated Oncogene-1 Expression in Basal Cell Carcinoma and Its Histologic Mimics.
    Gradecki SE; Eid MV; Pramoonjago P; Wick MR
    Am J Dermatopathol; 2021 Sep; 43(9):637-641. PubMed ID: 33264133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
    Bartoš V; Kullová M
    Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.